Farre MR - Search Results

1

Pharmacokinetic monitoring of antiepileptic drugs.

Aldaz A, Ferriols R, Aumente D, Calvo MV, Farre MR, García B, Marqués R, Mas P, Porta B, Outeda M, Soy D; Grupo PK-gen de la Sociedad Española de Farmacia Hospitalaria. Aldaz A, et al. Among authors: farre mr. Farm Hosp. 2011 Nov-Dec;35(6):326-39. doi: 10.1016/j.farma.2010.10.005. Epub 2011 May 13. Farm Hosp. 2011. PMID: 21570885 Free article. Review. English, Spanish.

2

Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.

Pichini S, Papaseit E, Joya X, Vall O, Farré M, Garcia-Algar O, de laTorre R. Pichini S, et al. Ther Drug Monit. 2009 Jun;31(3):283-318. doi: 10.1097/FTD.0b013e31819f3328. Ther Drug Monit. 2009. PMID: 19363463 Review.

3

[Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder: monitoring in biological matrices].

Papaseit E, García-Algar O, Simó S, Pichini S, Farré M. Papaseit E, et al. An Pediatr (Barc). 2013 Feb;78(2):123.e1-10. doi: 10.1016/j.anpedi.2012.08.015. Epub 2012 Oct 10. An Pediatr (Barc). 2013. PMID: 23063334 Free article. Spanish.

4

Usefulness of sweat testing for the detection of methylphenidate after fast- and extended-release drug administration: a pilot study.

Marchei E, Farré M, Pardo R, Garcia-Algar O, Pellegrini M, Pacifici R, Pichini S. Marchei E, et al. Ther Drug Monit. 2010 Aug;32(4):508-11. doi: 10.1097/FTD.0b013e3181e4e6f8. Ther Drug Monit. 2010. PMID: 20535053

5

Assessment of chronic exposure to MDMA in a group of consumers by segmental hair analysis.

Pichini S, Poudevida S, Pujadas M, Menoyo E, Pacifici R, Farré M, de la Torre R. Pichini S, et al. Ther Drug Monit. 2006 Feb;28(1):106-9. doi: 10.1097/01.ftd.0000189900.01060.92. Ther Drug Monit. 2006. PMID: 16418703

6

Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring.

Abanades S, Farré M, Segura M, Pichini S, Pastor A, Pacifici R, Pellegrini M, de la Torre R. Abanades S, et al. Ther Drug Monit. 2007 Feb;29(1):64-70. doi: 10.1097/FTD.0b013e3180307e5e. Ther Drug Monit. 2007. PMID: 17304152 Clinical Trial.

7

Determination of atomoxetine and its metabolites in conventional and non-conventional biological matrices by liquid chromatography-tandem mass spectrometry.

Marchei E, Papaseit E, Garcia-Algar OQ, Farrè M, Pacifici R, Pichini S. Marchei E, et al. J Pharm Biomed Anal. 2012 Feb 23;60:26-31. doi: 10.1016/j.jpba.2011.11.009. Epub 2011 Nov 17. J Pharm Biomed Anal. 2012. PMID: 22142618

8

Sweat testing for the detection of atomoxetine from paediatric patients with attention deficit/ hyperactivity disorder: application to clinical practice.

Marchei E, Papaseit E, Garcia-Algar O, Bilbao A, Farré M, Pacifici R, Pichini S. Marchei E, et al. Drug Test Anal. 2013 Mar;5(3):191-5. doi: 10.1002/dta.1415. Epub 2012 Sep 19. Drug Test Anal. 2013. PMID: 22991172

9

Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.

Marchei E, Farrè M, Pellegrini M, García-Algar O, Vall O, Pacifici R, Pichini S. Marchei E, et al. Forensic Sci Int. 2010 Mar 20;196(1-3):59-63. doi: 10.1016/j.forsciint.2009.12.038. Epub 2010 Jan 21. Forensic Sci Int. 2010. PMID: 20096514

10

Liquid chromatography-electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices.

Marchei E, Farrè M, Pellegrini M, Rossi S, García-Algar O, Vall O, Pichini S. Marchei E, et al. J Pharm Biomed Anal. 2009 Feb 20;49(2):434-9. doi: 10.1016/j.jpba.2008.11.020. Epub 2008 Nov 27. J Pharm Biomed Anal. 2009. PMID: 19117711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters